| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |